BE at Steady state [Design Issues]

posted by Ahmed meeran – 2006-09-12 08:10 (7224 d 23:22 ago) – Posting: # 249
Views: 13,486

Dear Dr. Helmut

All the regulatory guidlines talks about conducting Bioequivalence study in single dose and at steady state conditions. For which type of drugs conducting a Bioequivalence study at steady state conditions is necessary.

For performing Bioequivalence study at steady state whether the sample size calculation is same as that of single dose study.

If Bioequivalence study is performed at steady state whether it will meet the acceptance criteria with small no of subjects than a single dose study.

Please guide me in these issues

Ahmed

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
121 visitors (0 registered, 121 guests [including 19 identified bots]).
Forum time: 07:32 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5